Skip to main content

Hemolytic-Uremic Syndrome clinical trials at UCSF

1 research study open to eligible people

Hemolytic-uremic syndrome is a type of kidney disease. A clinical trial at UCSF is testing a new medicine called crovalimab for people with atypical hemolytic uremic syndrome. The trial will see if crovalimab is safe and effective in treating the disease.

Showing trials for

Last updated: